Alentis Therapeutics
Drug DiscoveryWebsite
Alentis Therapeutics valuation and funding history | Last updated: November 11, 2024 | 2 funding rounds
Current Valuation
N/A
As of November 11, 2024
Total Funding Raised
$362.5M
Across 2 rounds
Last Round
Later Stage VC
$181.4M
Last Funding
Nov 2024
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| November 11, 2024 | Later Stage VC (Series D) | $181.4M | N/A | - |
| April 13, 2023 | Later Stage VC (Series C) | $101.7M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Alentis Therapeutics is currently valued at N/A as of November 11, 2024. The company has raised a total of $362.5M in funding across 2 funding rounds.
What is Alentis Therapeutics Worth in 2026?
Alentis Therapeutics is a leading private company in the Drug Discovery sector. Track Alentis Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Alentis Therapeutics Valuation is Determined
Private company valuations like Alentis Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.